ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,813,475 | -51.6% | 15,238 | -27.5% | 0.00% | -50.0% |
Q2 2023 | $3,745,197 | +5.3% | 21,018 | -2.5% | 0.01% | 0.0% |
Q1 2023 | $3,555,382 | -0.7% | 21,553 | -5.2% | 0.01% | -11.1% |
Q4 2022 | $3,579,993 | +5.0% | 22,733 | +0.4% | 0.01% | 0.0% |
Q3 2022 | $3,410,000 | -10.1% | 22,643 | -1.9% | 0.01% | 0.0% |
Q2 2022 | $3,793,000 | -31.1% | 23,073 | -6.7% | 0.01% | -18.2% |
Q1 2022 | $5,507,000 | -6.2% | 24,733 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $5,870,000 | +1.2% | 24,733 | -0.5% | 0.01% | 0.0% |
Q3 2021 | $5,803,000 | +11.3% | 24,867 | -1.9% | 0.01% | +10.0% |
Q2 2021 | $5,216,000 | +0.2% | 25,343 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $5,206,000 | -4.2% | 25,343 | 0.0% | 0.01% | -9.1% |
Q4 2020 | $5,436,000 | +21.6% | 25,343 | +3.6% | 0.01% | +10.0% |
Q3 2020 | $4,472,000 | +5.1% | 24,469 | +5.9% | 0.01% | -9.1% |
Q2 2020 | $4,257,000 | -5.1% | 23,099 | +3.9% | 0.01% | -21.4% |
Q1 2020 | $4,487,000 | +7.2% | 22,239 | -0.5% | 0.01% | +40.0% |
Q4 2019 | $4,184,000 | +17.8% | 22,359 | +0.5% | 0.01% | +11.1% |
Q3 2019 | $3,551,000 | -36.2% | 22,249 | +0.6% | 0.01% | -35.7% |
Q2 2019 | $5,569,000 | +9.0% | 22,109 | +3.5% | 0.01% | 0.0% |
Q1 2019 | $5,110,000 | +15.8% | 21,353 | +11.1% | 0.01% | +7.7% |
Q4 2018 | $4,414,000 | -15.8% | 19,223 | +3.7% | 0.01% | 0.0% |
Q3 2018 | $5,242,000 | -2.2% | 18,538 | +1.6% | 0.01% | -7.1% |
Q2 2018 | $5,359,000 | +194.1% | 18,250 | +152.8% | 0.01% | +180.0% |
Q1 2018 | $1,822,000 | +16.8% | 7,220 | 0.0% | 0.01% | +25.0% |
Q4 2017 | $1,560,000 | +18.5% | 7,220 | +2.0% | 0.00% | 0.0% |
Q3 2017 | $1,316,000 | +7.8% | 7,080 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $1,221,000 | +13.0% | 7,080 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,081,000 | +5.6% | 7,080 | +1.9% | 0.00% | 0.0% |
Q4 2016 | $1,024,000 | +16.6% | 6,950 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $878,000 | +12.0% | 6,950 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $784,000 | +6.7% | 6,950 | -1.6% | 0.00% | -33.3% |
Q1 2016 | $735,000 | -36.7% | 7,064 | -31.4% | 0.00% | -25.0% |
Q4 2015 | $1,161,000 | +12.2% | 10,296 | +9.0% | 0.00% | 0.0% |
Q3 2015 | $1,035,000 | +14.5% | 9,450 | 0.0% | 0.00% | +33.3% |
Q2 2015 | $904,000 | -8.4% | 9,450 | -10.8% | 0.00% | 0.0% |
Q1 2015 | $987,000 | -18.4% | 10,596 | -28.2% | 0.00% | -25.0% |
Q4 2014 | $1,209,000 | +22.2% | 14,757 | -4.3% | 0.00% | +33.3% |
Q3 2014 | $989,000 | +5.3% | 15,413 | -0.2% | 0.00% | 0.0% |
Q2 2014 | $939,000 | +1.5% | 15,443 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $925,000 | -6.0% | 15,443 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $984,000 | -6.9% | 15,443 | -0.8% | 0.00% | 0.0% |
Q3 2013 | $1,057,000 | -2.2% | 15,563 | +3.7% | 0.00% | -25.0% |
Q2 2013 | $1,081,000 | – | 15,003 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |